Six germline variants of ATM were coupled with somatic ATM mutations in prostate adenocarcinoma, rectum adenocarcinoma, stomach adenocarcinoma, esophageal carcinoma, prostate adenocarcinoma, and bladder urothelial carcinoma. This evidence concerns the gene ATM and gastric adenocarcinoma.